The Prostate Cancer Foundation (PCF) is pleased to announce a request for applications for Young Investigator Awards. We especially encourage young investigators working on prostate cancer health disparities to apply.
PCF Young Investigator Awards will be three (3) years in duration and will provide $75,000 per year. The award funds may be used innovatively and flexibly to advance the career and research efforts of the awardee. This for example, includes funding “protected time” or direct costs for laboratory science. This award does not support indirect costs such as institutional overhead. Every PCF Young Investigator is required to be under the direct supervision of 1-3 mentors. Young Investigator awardees are required to attend the Annual PCF Scientific Retreat and Young Investigator Day, typically held in October, throughout the duration of their award.
PCF seeks applications from the global biomedical research community. Applicants traditionally under-represented in science and medicine are highly encouraged. We seek applications from early-career basic scientists, medical oncologists, pathologists, urologists, radiologists, radiation oncologists, public health experts, bioinformaticians, bioengineers, or professionals from any other field that could contribute to the end of prostate cancer. Applicants may be working in basic, translational, computational or clinical research and need not be trained specifically in prostate cancer research to be highly competitive. However, successful applicants should be working in an academic research environment capable of supporting transformational prostate cancer research. Access to and real-time interaction with a clinical environment and translational prostate cancer physician-scientists is highly desired.
Research proposals addressing disparities in care experienced by patients with prostate cancer may focus on implementation research in various populations (e.g. urban vs rural, racial, geographic or financial) or in biological drivers of care and outcome disparities that could potentially be addressed through changes in policy, advocacy or education. Applicants are encouraged to solicit and integrate advice from patients, patient support groups or advocates. Letters of support demonstrating such relationships are recommended.